MPH Health Care AG(GB:0W1Q)
€34.20+0.40 (+1.18%)
GB:0W1Q
MPH Health Care AG financials statements
€34.20
At close:+0.40 (+1.18%)
MPH Health Care AG (0W1Q) Ratios
0 Followers
MPH Health Care AG Ratios
GB:0W1Q's free cash flow for Q2 2026 was €0.00. For the 2026 fiscal year, GB:0W1Q's free cash flow was decreased by €-4.59M and operating cash flow was €4.59M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.17 | 0.52 | 1.42 | 0.29 | 1.06 |
| Quick Ratio | 0.17 | 0.52 | 1.42 | 0.29 | 1.06 |
| Cash Ratio | 0.11 | 0.18 | 0.91 | 0.12 | 0.44 |
| Solvency Ratio | 2.00 | 2.43 | 1.92 | 1.87 | -1.57 |
| Operating Cash Flow Ratio | 0.02 | 0.32 | -0.40 | -0.01 | -0.30 |
| Short-Term Operating Cash Flow Coverage | 0.02 | 0.34 | -0.43 | -0.01 | -0.32 |
| Net Current Asset Value | € -13.28M | € -10.18M | € -8.29M | € -11.61M | € -1.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.04 | 0.05 | 0.05 | 0.02 |
| Debt-to-Equity Ratio | 0.05 | 0.04 | 0.05 | 0.06 | 0.02 |
| Debt-to-Capital Ratio | 0.05 | 0.04 | 0.05 | 0.06 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.02 | 0.03 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | 1.05 | 1.06 | 1.07 | 1.03 |
| Debt Service Coverage Ratio | 3.35 | 5.17 | 5.70 | 2.23 | -2.10 |
| Interest Coverage Ratio | 65.61 | 34.15 | 52.42 | 174.46 | -46.63 |
| Debt to Market Cap | 0.12 | 0.11 | 0.18 | 0.20 | 0.04 |
| Interest Debt Per Share | 2.84 | 2.69 | 3.18 | 3.07 | 0.99 |
| Net Debt to EBITDA | 0.31 | 0.29 | 0.28 | 0.38 | -0.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 1740.35% | 99.34% | 92.02% |
| EBIT Margin | 9.36% | 544.72% | 419.31% | 432.76% | -208.05% |
| EBITDA Margin | 9.36% | 545.18% | 419.58% | 433.27% | -207.59% |
| Operating Profit Margin | 9.50% | 539.27% | 417.44% | 431.59% | -208.05% |
| Pretax Profit Margin | 9.36% | 528.93% | 411.35% | 430.28% | -210.68% |
| Net Profit Margin | 8.04% | 524.28% | 408.26% | 425.05% | -205.34% |
| Continuous Operations Profit Margin | 8.04% | 524.28% | 408.26% | 425.05% | -205.34% |
| Net Income Per EBT | 85.92% | 99.12% | 99.25% | 98.78% | 97.47% |
| EBT Per EBIT | 98.55% | 98.08% | 98.54% | 99.70% | 101.26% |
| Return on Assets (ROA) | 11.35% | 11.01% | 11.09% | 12.29% | -4.52% |
| Return on Equity (ROE) | 12.04% | 11.53% | 11.77% | 13.15% | -4.66% |
| Return on Capital Employed (ROCE) | 13.85% | 11.55% | 11.56% | 13.24% | -4.68% |
| Return on Invested Capital (ROIC) | 11.52% | 11.24% | 11.27% | 12.36% | -4.47% |
| Return on Tangible Assets | 11.35% | 11.01% | 11.09% | 12.29% | -4.52% |
| Earnings Yield | 31.11% | 33.12% | 41.45% | 44.45% | -9.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 3.46 | 4.11 | 0.00 | 0.00 |
| Payables Turnover | 0.57 | 0.00 | -2196.64 | 0.93 | 6.83 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 4185.77 | 46.81 | 962.71 | 312.38 | 105.14 |
| Asset Turnover | 1.41 | 0.02 | 0.03 | 0.03 | 0.02 |
| Working Capital Turnover Ratio | -75.17 | -18.11 | -1.88 | -1.44 | -51.05 |
| Cash Conversion Cycle | -636.48 | 105.37 | 88.89 | -394.03 | -53.41 |
| Days of Sales Outstanding | 0.00 | 105.37 | 88.72 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 636.48 | 0.00 | -0.17 | 394.03 | 53.41 |
| Operating Cycle | 0.00 | 105.37 | 88.72 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | 0.43 | -0.47 | -0.04 | -0.30 |
| Free Cash Flow Per Share | 0.03 | 0.43 | -0.47 | -0.04 | -0.30 |
| Dividend Paid and CapEx Coverage Ratio | 0.03 | 0.36 | -429.18 | -29.35 | -564.13 |
| Capital Expenditure Coverage Ratio | 16.65 | 440.96 | -429.18 | -29.35 | -564.13 |
| Operating Cash Flow Coverage Ratio | 0.01 | 0.17 | -0.15 | -0.01 | -0.32 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.30 | -0.28 | -0.02 | -0.29 |
| Free Cash Flow Yield | 0.13% | 1.89% | -2.84% | -0.26% | -1.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3.22 | 3.02 | 2.41 | 2.25 | -10.18 |
| Price-to-Sales (P/S) Ratio | 0.26 | 15.83 | 9.85 | 9.56 | 20.91 |
| Price-to-Book (P/B) Ratio | 0.39 | 0.35 | 0.28 | 0.30 | 0.47 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 765.62 | 53.01 | -35.27 | -384.40 | -71.09 |
| Price-to-Operating Cash Flow Ratio | 719.63 | 52.89 | -35.35 | -397.50 | -71.21 |
| Price-to-Earnings Growth (PEG) Ratio | -0.38 | 0.36 | 1.64 | -0.01 | 0.12 |
| Enterprise Value Multiple | 3.08 | 3.19 | 2.63 | 2.59 | -10.32 |
| Enterprise Value | 104.88M | 106.29M | 79.79M | 76.83M | 93.40M |
| EV to EBITDA | 3.08 | 3.19 | 2.63 | 2.59 | -10.32 |
| EV to Sales | 0.29 | 17.39 | 11.03 | 11.22 | 21.41 |
| EV to Free Cash Flow | 852.55 | 58.23 | -39.48 | -450.85 | -72.81 |
| EV to Operating Cash Flow | 801.34 | 58.09 | -39.57 | -466.21 | -72.94 |
| Tangible Book Value Per Share | 56.86 | 64.90 | 58.62 | 51.72 | 44.92 |
| Shareholders’ Equity Per Share | 56.86 | 64.90 | 58.62 | 51.72 | 44.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.01 | 0.01 | 0.01 | 0.03 |
| Revenue Per Share | 85.10 | 1.43 | 1.69 | 1.60 | 1.02 |
| Net Income Per Share | 6.84 | 7.48 | 6.90 | 6.80 | -2.09 |
| Tax Burden | 0.86 | 0.99 | 0.99 | 0.99 | 0.97 |
| Interest Burden | 1.00 | 0.97 | 0.98 | 0.99 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.19 | 0.16 | 0.14 | 0.21 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.00 | 0.06 | -0.07 | -0.01 | 0.14 |
Currency in EUR

